LEVEL 4 B01AD07

Δραστικές

RETEPLASE

Φάρμακα

  • DRUGBANK - Reteplase
  • indication:

    For lysis of acute pulmonary emboli, intracoronary emboli and management of myocardial infarction

  • pharmacology:

  • mechanism:

    Reteplase binds to fibrin rich clots via the fibronectin finger-like domain and the Kringle 2 domain. The protease domain then cleaves the Arg/Val bond in plasminogen to form plasmin. Plasmin in turn degrades the fibrin matrix of the thrombus, thereby exerting its thrombolytic action.

  • toxicity:

  • absorprion:

  • halflife:

  • roouteelimination:

  • volumedistribution:

  • clearance: